SFRP2 and psoriasis: Although further investigations are required to understand the comprehensive molecular mechanisms of abovementioned CMKLR, COL8A, NRK, SYTL2, and SFRP2 genes, this study suggests the potential use of CMKLR, COL8A, NRK, SYTL2, and SFRP2 as a therapeutic target for psoriasis in the future.